A selective PI 3-Kγ isoform inhibitor (IC50 = 0.24, 1.45, 0.07 and 1.70μM for α, β, γ and δ isoforms respectively). Blocks RANTES-induced neutrophil migration and displays anti-inflammatory activity in various in vivo rodent models.
Product Specification
| Alternative Name: | NSC31098, 5-Benzo[1,3]dioxol-5-ylmethylene-thiazolidine-2,4-dione |
| |
| Formula: | C11H7NO4S |
| |
| MW: | 249.2 |
| |
| CAS: | 6318-41-8 |
| |
| Purity: | ≥98% (TLC) |
| |
| Appearance: | Yellow solid. |
| |
| Solubility: | Soluble in DMSO (25mg/mL). For in vivo administration this compound was suspended in 0.5% carboxymethylcellulose/0.25% Tween 20 as a vehicle. |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | Ambient |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment: C. Ferrandi, et al.; J. Pharmacol. Exp. Ther.
322, 923 (2007),
Abstract;
